Trial intelligence / Profile preview

Influence factors of corneal biomechanical properties in adolescents with myopia

ChiCTR2100049751Phase 4Not yet recruiting

Sponsor
Wuhan Hongshan Aier Eye Hospital
Start
Aug 2021
Modality
Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of atropine in myopia, sponsored by Wuhan Hongshan Aier Eye Hospital. Primary endpoints: Corneal biomechanical parameters and Axial length. Planned start Aug 2021; status: not yet recruiting.

02

Drugs

atropine
03

Conditions

myopia

Beyond the preview

Go deeper on ChiCTR2100049751.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100049751.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call